Bringing patient-centered tuberculosis diagnosis into the light of day.

J Lucian Davis

Abstract readLetterComment

In one paragraph

Article in BMC medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Simulated patients and their reality: An inquiry into theory and method.Social science & medicine (1982) · 2022
Article

4 · The record

Corrections and comments

Comment on
Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis.2017

5 · Who and what money

Authors and funding

1 author.

J Lucian DavisDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, 60 College Street, Room 620, New Haven, Connecticut, 06520-8034, USA. lucian.davis@yale.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026

$102.9M

NCATS NIH HHS UL1 TR001863

6 · The paper itself

Abstract

In 2015, the WHO End TB Strategy laid out ambitious goals to dramatically reduce tuberculosis (TB) deaths, incidence, and catastrophic costs through research, bold new strategies, and patient-centered care. In this commentary, recent evidence on sputum collection strategies for smear microscopy is reviewed, and the argument is made that redesigning smear microscopy as a patient-centered service offers the only realistic and widely available strategy to advance TB diagnostic care towards the initial End TB Strategy goals laid out for 2025. Finally, the successful adoption of same-day sputum smear microscopy as a model for patient-centered TB care is suggested to be synergistic with and to form part of the scale-up of new TB diagnostic tools.Please see related article: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0947-9.

Indexed as

Patient-Centered CareAdultCosts and Cost AnalysisDiagnostic Tests, RoutineHumansIncidenceMicroscopySputumTuberculosisTuberculosis, PulmonaryDiagnosisFluorescence microscopyPatient-centered carePrognosisTuberculosis

Identifiers

PMID29258526

DOI10.1186/s12916-017-0992-4

PMCPMC5738029

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.